Page 337 - Drug Class Review

Final Report Update 1 Drug Effectiveness Review Project

25. Rogers SL, Friedhoff LT. Donepezil provides long-term clinical benefits for patients with alzheimer's
Disease (AD) [Abstract]. Journal of the Neurological Sciences 1997(Sept):S296.

26. Small G, Mendiondo MS, Quarg P, and SR. Efficacy of rivastigmine treatment in Alzheimer's disease
over 5 years. 42nd American College of Neuropsychopharmacology Annual Meeting, San Juan,
Puerto Rico, 7-11 December 2003.

27. Smith F, Gracon S, Knopman D, and SL. Survival Analysis to Evaluate the Effect of Long-Term
Tacrine (Cognex) Treatment on Nursing Home Placement in Alzheimer Patients. Journal of
Neurology 1997;244(Suppl 3):S88.

28. Tariot P, Cummings JL, Katz IR, Perdomo CA, Whalen E, Sovel MA, et al. Donepezil was well-
tolerated and enhanced cognition in nursing home patients with alzheimer's disease. Journal of the
American Geriatrics Society 1999;47:S3.

29. Tiseo PJ, Rogers SL, Friedhoff LT. Co-administration of donepezil and digoxin produces no
pharmacokinetic or pharmacodynamic interactions. 10th European College of
Neuropsychopharmacology Congress. Vienna, Austria. 13th-17th September 1997. 1997.

30. Tiseo PJ, Rogers SL, Friedhoff LT. The pharmacokinetics and pharmacodynamics of (R)- and (S)-
Warfarin are unaffected by co-administration of donepezil. 10th European College of
Neuropsychopharmacology Congress. Vienna, Austria. 13th-17th September 1997. 1997.

31. Triau E, Boada M, Sakka P, et a. Efficacy and safety of donepezil hydrochloride in patients with AD:
preliminary findings from a large, multinational experience study. Journal of Neurology
2001;248(Suppl 2):II/133.

32. Tune LE, Tiseo PJ, Hoffman JM, Perdomo CA, Votow JR, Rogers SL, et al. Functional Brain
Activity in Alzheimer's Disease. 151st Annual Meeting of the American Psychiatric Association.
Toronto, Ontario, Canada. 30th May-4th June 1998. 1998(NR345).

33. Tune L, Tiseo P, Hoffman J, Perdomo C, Votaw J, Rogers S, et al. PET in AD: Donepezil HCl
(E2020) maintains functional brain activity in patients with Alzheimer's disease: results of a 24-week
study. 14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 23rd-26th
February; San Francisco, CA, USA 2001.

34. Veach K, Sm, Doraiswamy PM. Rivastigmine slows stage-specific global deterioration in alzheimer's
disease. 152nd Annual Meeting of the American Psychiatric Association. Washington DC, USA. 15-
20th May, 1999. 1999.

35. Waldemar G, Winblad B, Engedal K, Soininen HS, Verhey FR, Wimo A, et al. Donepezil benefits
patients with either mild of moderate Alzheimer's disease over one year. Neurology 2000;54(Suppl
3):A470.

36. Wilkinson D, Passmore P, Potocnik F, Maud C, Hock C. Donepezil compared to rivastigmine in
Alzheimer's disease: similar efficacy but better tolerability and physician and caregiver satisfaction
in a multinational randomized trial. 14th Annual Meeting of the American Association for Geriatric
Psychiatry; 2001 23rd-26th February; San Francisco, CA, USA 2001.

Alzheimer's Drugs Page 204 of 205